Home › Trial NCT01245816
A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)
- Trial IDNCT01245816
- StatusWithdrawn
- PhasePhase 3
- Study typeInterventional
- SponsorCancer Prevention Pharmaceuticals, Inc.
- Enrollment—
- Start date2011-03
- ConditionsFamilial Adenomatous Polyposis
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.